Zhang (5) reported a case of SLE with stage IV diffuse large B cell lymphoma (DLBCL) that achieved stable remission following anti-BCMA/CD19 CAR-T therapy (Figure 2C). The gene discussed is CD19; the disease is systemic lupus erythematosus.